logo

For the Inventor, By the Inventor

Lawrenceville, NJ, United States of America

Kathleen M Poss

This inventor holds 11 USPTO granted patents, plus 1 CIPO patent. Top assignees: Fmc Corporation, Bristol-Myers Squibb Compnay, E. R. Squibb Sons, Inc.. Active years: 1990-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathleen M Poss. Retrieved from https://idiyas.com/inventor/kathleen-m-poss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.7

ph-index = 5

Forward Citations = 349(Granted Patents)


Company Filing History:

goldMedal5 out of 2,517 
 
Fmc Corporation
 patents
silverMedal4 out of 3,742 
 
Bristol-Myers Squibb Compnay
 patents
bronzeMedal2 out of 1,624 
 
E. R. Squibb Sons, Inc.
 patents

Years Active: 1990-1998

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 5776983 - Catecholamine surrogates useful as .beta..sub.3 agonists (1998-07-07),
2. 5770615 - Catecholamine surrogates useful as .beta..sub.3 agonists (1998-06-23),
3. 5723489 - Aryloxypropanolamine beta 3 adrenergic agonists (1998-03-03),
4. 5541204 - Aryloxypropanolamine .beta. 3 adrenergic agonists (1996-07-30),
5. 5369123 - Nitrogen-substituted mevinic acid derivatives useful as HMG-CoA (1994-11-29),
6. 5286746 - Sulfur-substituted mevinic acid derivatives (1994-02-15),
7. 5217520 - Herbicidal triazolinones (1993-06-08),
8. 5208212 - Herbicidal compositions containing triazolinones (1993-05-04),
9. 5125958 - Herbicidal triazolinones (1992-06-30),
10. 5035740 - Herbicidal compounds (1991-07-30),
11. 4913724 - Herbicidal tetrazolinones (1990-04-03),

Title: The Innovative Contributions of Kathleen M Poss

Introduction

Kathleen M Poss is a prominent inventor based in Lawrenceville, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target beta three adrenergic receptors. With a total of 11 patents to her name, her work has implications for treating various health conditions, including diabetes and obesity.

Latest Patents

Among her latest patents are innovative compounds described as catecholamine surrogates useful as beta-3 agonists. These compounds are characterized by specific chemical formulas and are designed to be pharmaceutically acceptable salts. The compounds are particularly valuable in the treatment of diabetes, obesity, and gastrointestinal diseases, showcasing her commitment to addressing critical health issues.

Career Highlights

Kathleen has worked with notable companies such as FMC Corporation and Bristol-Myers Squibb Company. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in pharmaceutical research and development.

Collaborations

Throughout her career, Kathleen has collaborated with esteemed colleagues, including William N Washburn and Philip Michael Sher. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Kathleen M Poss exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations have the potential to significantly impact healthcare and improve the quality of life for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…